Get Real Time Here
| Open26.940 | Close- |
| Vol / Avg.100.508K / 2.157M | Mkt Cap11.886B |
| Day Range26.611 - 27.010 | 52 Wk Range25.920 - 44.460 |
Royalty Pharma Stock (NASDAQ:RPRX), Quotes and News Summary
Royalty Pharma Stock (NASDAQ: RPRX) stock price, news, charts, stock research, profile.
| Open26.940 | Close- |
| Vol / Avg.100.508K / 2.157M | Mkt Cap11.886B |
| Day Range26.611 - 27.010 | 52 Wk Range25.920 - 44.460 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.770 | 0.790 | 0.0200 | ||||
| REV | 614.360M | 536.000M | -78.360M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-09 | Morgan Stanley | Terence Flynn | Maintains | OverweightOverweight | Raises | 54.00 | 57.00 |
| 2023-10-11 | Morgan Stanley | Terence Flynn | Maintains | OverweightOverweight | Raises | 53.00 | 54.00 |
| 2023-08-09 | Morgan Stanley | Terence Flynn | Maintains | OverweightOverweight | Raises | 52.00 | 53.00 |
| 2023-07-11 | Morgan Stanley | Terence Flynn | Reiterates | OverweightOverweight | Maintains | 52.00 | 52.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RPRX | Royalty Pharma | -1.08% | 11.9B |
| NVO | Novo Nordisk | -0.5% | 452.7B |
| JNJ | Johnson & Johnson | 0.4% | 367.6B |
| MRK | Merck & Co | -0.46% | 255.1B |
| NVS | Novartis | -0.12% | 199.2B |
How do I buy Royalty Pharma (RPRX) stock?
You can purchase shares of Royalty Pharma (NASDAQ: RPRX) through any online brokerage.
Who are Royalty Pharma's (RPRX) competitors?
Other companies in Royalty Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
What is the target price for Royalty Pharma (RPRX) stock?
The latest price target for Royalty Pharma (NASDAQ: RPRX) was reported by Morgan Stanley on Thursday, November 9, 2023. The analyst firm set a price target for 57.00 expecting RPRX to rise to within 12 months (a possible 114.21% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Royalty Pharma (RPRX)?
The stock price for Royalty Pharma (NASDAQ: RPRX) is $26.61 last updated Today at November 30, 2023 at 3:01 PM UTC.
Does Royalty Pharma (RPRX) pay a dividend?
A quarterly cash dividend of $0.20 per share of Class A Common Stock. The quarterly cash dividend was payable on December 15, 2023 to stockholders of record on November 16, 2023.
When is Royalty Pharma (NASDAQ:RPRX) reporting earnings?
Royalty Pharma’s Q4 earnings are confirmed for Wednesday, February 14, 2024.
Is Royalty Pharma (RPRX) going to split?
There is no upcoming split for Royalty Pharma.
What sector and industry does Royalty Pharma (RPRX) operate in?
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.